AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louheranta, A. M
Right arrow Articles by Uusitupa, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louheranta, A. M
Right arrow Articles by Uusitupa, M. I.
Agricola
Right arrow Articles by Louheranta, A. M
Right arrow Articles by Uusitupa, M. I.
American Journal of Clinical Nutrition, Vol. 76, No. 2, 331-337, August 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance1,2,3

Anne M Louheranta, Essi S Sarkkinen, Helvi M Vidgren, Ursula S Schwab and Matti IJ Uusitupa

1 From the Department of Clinical Nutrition, University of Kuopio (AML, ESS, HMV, USS, and MIJU), Kuopio, Finland.

Background: Both the amount and quality of dietary fat can modify glucose and insulin metabolism.

Objective: The objective was to examine the relation between serum lipid fatty acids and glucose metabolism before and after the consumption of a diet enriched in either monounsaturated (Mono diet) or polyunsaturated (Poly diet) fatty acids.

Design: After consuming a high-saturated-fat run-in diet for 3 wk, 31 subjects with impaired glucose tolerance were randomly counseled to consume the Mono [40% fat; 11%, 19%, and 8% of energy as saturated, monounsaturated, and polyunsaturated fatty acids (S:M:P), respectively] or the Poly (34% fat; S:M:P of 11%:10%:10%) diet for 8 wk. Serum lipid fatty acids were measured, and an intravenous-glucose-tolerance test was performed at baseline and at 8 wk.

Results: At baseline, a higher glucose effectiveness (SG) was associated with higher proportions of oleic (r = 0.57, P = 0.04) and {alpha}-linolenic (r = 0.64, P = 0.01) acids in phospholipids. An increase in the proportions of oleic and {alpha}-linolenic acids in phospholipids was associated with a decrease in fasting plasma glucose [r = -0.53 (P = 0.002) and r = -0.47 (P = 0.009), respectively]. An increase in the SG was associated with an increase in the proportion of oleic acid (r = 0.55, P = 0.004) and with a decrease in that of arachidonic acid (r = -0.40, P = 0.04) in phospholipids.

Conclusions: The beneficial changes in fasting plasma glucose and in the SG during the Mono diet were associated with alterations in the proportions of oleic, {alpha}-linolenic, and arachidonic acids in phospholipids.

Key Words: Dietary fats • serum fatty acid profile • lipids • glucose metabolism • impaired glucose tolerance • fat-modified diet




This article has been cited by other articles:


Home page
Clin. Chem.Home page
M. A. Pereira and D. S. Ludwig
Surveillance of Insulin Resistance in Children
Clin. Chem., April 1, 2003; 49(4): 540 - 541.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition